Amylyx Pharmaceuticals, Inc. (AMLX) › Total LiabilitiesAmylyx Pharmaceuticals, Inc. (AMLX) — Total LiabilitiesAnnual figures by period end, from SEC filings.2021-12-31: $17.43M2022-12-31: $50.85M2023-12-31: $84.02M2024-12-31: $28.87M2025-12-31: $27.39M$27.39M2021-12-31Total Liabilities (USD)2025-12-31Period endedTotal LiabilitiesChange YoYSource filing2025-12-31$27.39M-5.1%2026-03-03Balance as of period end2024-12-31$28.87M-65.6%2026-03-03Balance as of period end2023-12-31$84.02M+65.2%2025-03-04Balance as of period end2022-12-31$50.85M+191.7%2024-02-22Balance as of period end2021-12-31$17.43M—2023-03-13Balance as of period endOther metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)